Agios Pharmaceuticals
Cambridge
About Agios Pharmaceuticals
Agios Pharmaceuticals is a biopharmaceutical company, discovers and develops therapeutics in the field of cancer metabolism. It also develops drugs that focus on glycolysis, fatty acid metabolism, and autophagy. The company's therapeutics are used in the areas of autoimmune, inflammatory, and neurological diseases. Agios Pharmaceuticals was formerly known as CANCER METABOLISM THERAPEUTICS And changed its name to Agios Pharmaceuticals In April 2008. The company is based in Cambridge, Massachusetts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Estimated revenue: $10K – $50K
- Total funding: $775.8M
- Funding stage: M&A
- Last round: Post-IPO Equity (Nov 2019)
- Ticker: nasdaq:AGIO
- Website: agios.com
- Phone: +1 617 649 8600
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/agios-pharmaceuticals-58347 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.